EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Quantifying the ‘distance to LDL-C goal’ in patients at very high cardiovascular risk with hyperlipidaemia in Germany: a retrospective claims database analysis

Ksenija Stach iD, Hartmut Richter, Uwe Fraass, Alexandra Stein

Therapeutic Advances in Cardiovascular Disease · 2024

DOI: 10.1177/17539447241277402 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Advances in Cardiovascular Disease, 2024. Verfasst von Ksenija Stach und 3 weiteren Autor:innen. Beteiligte Einrichtung: 5th Medical Department, University Hospital Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, Mannheim 68167, Germany. Hauptthemen laut MEDLINE: Hyperlipidemias, Cholesterol, LDL, Cardiovascular Diseases, Databases, Factual. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Amgen GmbH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objectives: This study quantified the ‘distance to LDL-C goal’ in patients at very high cardiovascular risk with uncontrolled hyperlipidaemia. ‘Distance to LDL-C goal’ was defined as the percentage by which low-density lipoprotein cholesterol (LDL-C) levels needed to be reduced to achieve the LDL-C goals specified in the 2016 or 2019 European Society of Cardiology/European Atherosclerosis Society guidelines. Design and methods: This retrospective analysis using data from the IQVIA Disease Analyzer database included patients who were predominantly treated by a primary care physician, diabetologist or cardiologist between 2014 and 2018, with a diagnosis of hyperlipidaemia and an initial LDL-C measurement (index event) and one or more cardiovascular risk factors. The primary outcome was to assess the proportion of patients with uncontrolled hyperlipidaemia and to classify the ‘distance to LDL-C goal’ in these patients.

Results

Data from 32,963 patients were analysed ( n = 27,159, n = 3873 and n = 1931 patients in the primary care physician, diabetology and cardiology cohorts, respectively). Most patients had uncontrolled LDL-C levels (⩾70 mg/dL; ⩾1.8 mmol/L) at index (91.0%, 86.4% and 94.0% of patients in the primary care physician, diabetology and cardiology cohorts, respectively). Analysis of the ‘distance to LDL-C goal’ indicated that approximately one-third of patients in each cohort required an LDL-C level reduction of up to 50% relative to index to achieve their LDL-C goal (35.8%, 43.7% and 28.4% of patients in the primary care physician, diabetology and cardiology cohorts, respectively). LDL-C control was not achieved at 36 months post-index in most patients with uncontrolled LDL-C levels (86.8%, 81.7% and 90.2% of patients in the primary care physician, diabetology and cardiology cohorts, respectively).

Conclusion

LDL-C levels were uncontrolled in most patients with hyperlipidaemia. Analysis of the ‘distance to LDL-C goal’ showed that most patients required a substantial LDL-C level reduction to achieve their LDL-C goal.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperlipidemiasCholesterol, LDLCardiovascular DiseasesDatabases, FactualHeart Disease Risk FactorsBiomarkersHumansRetrospective StudiesMaleFemaleMiddle AgedGermanyAgedRisk AssessmentTime FactorsTreatment OutcomeAdministrative Claims, HealthcareHydroxymethylglutaryl-CoA Reductase Inhibitors

Stichwörter der Autor:innen

LDL-C goalsLDL-C reductionLDL-C targetcardiovascular risklipid-lowering therapylow-density lipoprotein cholesterol

Substanzen

Cholesterol, LDLBiomarkersHydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • 5th Medical Department, University Hospital Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, Mannheim 68167, Germany.
  • IQVIA Epidemiology, IQVIA, Frankfurt/Main, Germany.
  • Amgen GmbH, Munich, Germany.

ORCID-Profile: Ksenija Stach

Förderung

  • Amgen GmbH

Zitieren

APA

Stach, K., Richter, H., Fraass, U., & Stein, A. (2024). Quantifying the ‘distance to LDL-C goal’ in patients at very high cardiovascular risk with hyperlipidaemia in Germany: a retrospective claims database analysis. Therapeutic Advances in Cardiovascular Disease. https://doi.org/10.1177/17539447241277402

Vancouver

Stach K, Richter H, Fraass U, Stein A. Quantifying the ‘distance to LDL-C goal’ in patients at very high cardiovascular risk with hyperlipidaemia in Germany: a retrospective claims database analysis. Therapeutic Advances in Cardiovascular Disease. 2024. doi:10.1177/17539447241277402

BibTeX
@article{Stach2024,
  author = {Stach, Ksenija and Richter, Hartmut and Fraass, Uwe and Stein, Alexandra},
  title = {Quantifying the ‘distance to LDL-C goal’ in patients at very high cardiovascular risk with hyperlipidaemia in Germany: a retrospective claims database analysis},
  journal = {Therapeutic Advances in Cardiovascular Disease},
  year = {2024},
  doi = {10.1177/17539447241277402}
}
Kostenlos starten →